— Research monograph
Melanotan II
A synthetic analog of α-melanocyte-stimulating hormone studied for melanogenesis.
Updated
- Class
- Cyclic lactam α-MSH analog — non-selective melanocortin receptor agonist
- Half-life (research)
- ~1 hr (preclinical and early-clinical reports).
- Origin
- Developed at the University of Arizona by Mac Hadley, Victor Hruby, and colleagues in the late 1980s as a superpotent cyclic analog of α-melanocyte stimulating hormone with extended stability and bioavailability.
- Solubility
- Physicochemical context only. Merit Sciences publishes no reconstitution or preparation procedures.
What is Melanotan II?
Melanotan II (MT-II) is a synthetic cyclic lactam heptapeptide derived from α-MSH. The cyclization (between Asp5 and Lys10) plus the substitution of D-Phe at position 7 produced a "superpotent" non-selective melanocortin receptor agonist that became a frequent reference compound in melanocortin pharmacology research.
MT-II binds with high affinity at MC1R, MC3R, MC4R, and MC5R. The receptor-promiscuous profile contrasts with the more MC3R/MC4R-preferential PT-141 (which was, in fact, developed as a metabolite of MT-II).
How does Melanotan II work?
Pan-melanocortin receptor agonist. MC1R activation drives melanogenesis in dermal melanocyte research. MC3R and MC4R activation in hypothalamic populations modulates appetite, energy expenditure, and sexual response in preclinical models.
Research applications
- Melanogenesis research
- Melanocortin receptor pharmacology
- Comparative MC-receptor selectivity studies
- Appetite-regulation preclinical models
Melanotan II at Merit
Research review on The Assay, Merit’s editorial publication: PT-141 vs Melanotan II: What the Research Compares
Form & storage
Melanotan II ships as a sealed, lyophilized (freeze-dried) powder. Physicochemical context only. Merit Sciences publishes no reconstitution or preparation procedures. Store sealed, light-protected, and follow your institution’s handling procedures for research materials.
Frequently asked questions
What is Melanotan II?
Melanotan II (MT-II) is a synthetic cyclic lactam heptapeptide derived from α-MSH. The cyclization (between Asp5 and Lys10) plus the substitution of D-Phe at position 7 produced a "superpotent" non-selective melanocortin receptor agonist that became a frequent reference compound in melanocortin pharmacology research. Merit supplies it as a lyophilized research compound for research use only, not for human or veterinary use.
How does Melanotan II work?
Pan-melanocortin receptor agonist. MC1R activation drives melanogenesis in dermal melanocyte research. MC3R and MC4R activation in hypothalamic populations modulates appetite, energy expenditure, and sexual response in preclinical models. Mechanistic descriptions summarize published preclinical findings and are not clinical claims.
What is the half-life of Melanotan II?
~1 hr (preclinical and early-clinical reports). Values reflect preclinical or research-context reports, not clinical pharmacokinetics.
Is Merit Melanotan II for human use?
No. It is sold strictly for research use only: not for human or veterinary use, and not for diagnostic or therapeutic use.
Is Melanotan II FDA-approved?
Not approved by the FDA for any use. Supplied for research use only.
How is each batch of Melanotan II tested?
Every Merit batch is tested by an independent laboratory for identity and HPLC purity before it is listed, and Merit identifies batches by date rather than by lot number. Current certificates: Melanotan II 10 mg, June 2026 batch, 99.617% purity (meritsciences.com/coa/MRT-2606-06).
Regulatory status checked October 22, 2026 against: Drugs@FDA, FDA Category 2 list.
References
- Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Dorr RT, Lines R, Levine N, et al.. Life Sciences, 1996 · PMID 8637402
- Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Hadley ME, Dorr RT. Peptides, 2006 · PMID 16412534
- Discovery that a melanocortin regulates sexual functions in male and female humans. Hadley ME. Peptides, 2005 · PMID 15996790
For research use only. Not for human or veterinary use. Reference information summarized from published literature, not medical advice.